TY - JOUR
T1 - The ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)
T2 - Results from the OSIPI-Dynamic Contrast-Enhanced challenge
AU - OSIPI
AU - Shalom, Eve S
AU - Kim, Harrison
AU - van der Heijden, Rianne A
AU - Ahmed, Zaki
AU - Patel, Reyna
AU - Hormuth, David A
AU - DiCarlo, Julie C
AU - Yankeelov, Thomas E
AU - Sisco, Nicholas J
AU - Dortch, Richard D
AU - Stokes, Ashley M
AU - Inglese, Marianna
AU - Grech-Sollars, Matthew
AU - Toschi, Nicola
AU - Sahoo, Prativa
AU - Singh, Anup
AU - Verma, Sanjay K
AU - Rathore, Divya K
AU - Kazerouni, Anum S
AU - Partridge, Savannah C
AU - LoCastro, Eve
AU - Paudyal, Ramesh
AU - Wolansky, Ivan A
AU - Shukla-Dave, Amita
AU - Schouten, Pepijn
AU - Gurney-Champion, Oliver J
AU - Jiřík, Radovan
AU - Macíček, Ondřej
AU - Bartoš, Michal
AU - Vitouš, Jiří
AU - Das, Ayesha Bharadwaj
AU - Kim, S Gene
AU - Bokacheva, Louisa
AU - Mikheev, Artem
AU - Rusinek, Henry
AU - Berks, Michael
AU - Hubbard Cristinacce, Penny L
AU - Little, Ross A
AU - Cheung, Susan
AU - O'Connor, James P B
AU - Parker, Geoff J M
AU - Moloney, Brendan
AU - LaViolette, Peter S
AU - Bobholz, Samuel
AU - Duenweg, Savannah
AU - Virostko, John
AU - Laue, Hendrik O
AU - Sung, Kyunghyun
AU - Nabavizadeh, Ali
AU - Saligheh Rad, Hamidreza
N1 - © 2023 International Society for Magnetic Resonance in Medicine.
PY - 2024/5
Y1 - 2024/5
N2 - PURPOSE:
K
trans
$$ {K}^{\mathrm{trans}} $$
has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for
K
trans
$$ {K}^{\mathrm{trans}} $$
quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging-Dynamic Contrast-Enhanced (OSIPI-DCE) challenge was designed to benchmark methods to better help the efforts to standardize
K
trans
$$ {K}^{\mathrm{trans}} $$
measurement.
METHODS: A framework was created to evaluate
K
trans
$$ {K}^{\mathrm{trans}} $$
values produced by DCE-MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for
K
trans
$$ {K}^{\mathrm{trans}} $$
quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants'
K
trans
$$ {K}^{\mathrm{trans}} $$
values, the applied software, and a standard operating procedure. These were evaluated using the proposed
OSIP
I
gold
$$ \mathrm{OSIP}{\mathrm{I}}_{\mathrm{gold}} $$
score defined with accuracy, repeatability, and reproducibility components.
RESULTS: Across the 10 received submissions, the
OSIP
I
gold
$$ \mathrm{OSIP}{\mathrm{I}}_{\mathrm{gold}} $$
score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0-1 = lowest-highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in
K
trans
$$ {K}^{\mathrm{trans}} $$
analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.
CONCLUSIONS: This study reports results from the OSIPI-DCE challenge and highlights the high inter-software variability within
K
trans
$$ {K}^{\mathrm{trans}} $$
estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real-world clinical setting, many of these tools may perform differently with different benchmarking methodology.
AB - PURPOSE:
K
trans
$$ {K}^{\mathrm{trans}} $$
has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for
K
trans
$$ {K}^{\mathrm{trans}} $$
quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging-Dynamic Contrast-Enhanced (OSIPI-DCE) challenge was designed to benchmark methods to better help the efforts to standardize
K
trans
$$ {K}^{\mathrm{trans}} $$
measurement.
METHODS: A framework was created to evaluate
K
trans
$$ {K}^{\mathrm{trans}} $$
values produced by DCE-MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for
K
trans
$$ {K}^{\mathrm{trans}} $$
quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants'
K
trans
$$ {K}^{\mathrm{trans}} $$
values, the applied software, and a standard operating procedure. These were evaluated using the proposed
OSIP
I
gold
$$ \mathrm{OSIP}{\mathrm{I}}_{\mathrm{gold}} $$
score defined with accuracy, repeatability, and reproducibility components.
RESULTS: Across the 10 received submissions, the
OSIP
I
gold
$$ \mathrm{OSIP}{\mathrm{I}}_{\mathrm{gold}} $$
score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0-1 = lowest-highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in
K
trans
$$ {K}^{\mathrm{trans}} $$
analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.
CONCLUSIONS: This study reports results from the OSIPI-DCE challenge and highlights the high inter-software variability within
K
trans
$$ {K}^{\mathrm{trans}} $$
estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real-world clinical setting, many of these tools may perform differently with different benchmarking methodology.
KW - DCE-MRI
KW - challenge
KW - data analysis
KW - glioblastoma
KW - open-science
KW - perfusion
UR - http://www.scopus.com/inward/record.url?scp=85180171278&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/3ec81377-dd06-3fd8-a0b6-35464466c558/
U2 - 10.1002/mrm.29909
DO - 10.1002/mrm.29909
M3 - Article
C2 - 38115695
SN - 0740-3194
VL - 91
SP - 1803
EP - 1821
JO - Magnetic Resonance in Medicine
JF - Magnetic Resonance in Medicine
IS - 5
ER -